Abstract:Jean Pierre Gafaranga, 1, 2 Leopold Bitunguhari, 3, 4 Charles Mudenge, 1, 5 Felix Manirakiza, 6, 7 Brian Kelly, 8 Paul Gatabazi 9– 11 1 Department of Psychiatry and Behavioral Sciences, School of Medicine and Pharmacy, University of Rwanda, Kigali, Rwanda; 2 Department of Mental Health, University Teaching Hospital of Kigali, Kigali, Rwanda; 3 Department of Internal Medicine, University Teaching Hospital of Kigali, Kigali, Rwanda; 4 Department of Internal Medicine, School of Medicine and Pharmacy, University of Rwanda, Kigali, Rwanda; 5 Department of Psychiatry, Ndera Neuropsychiatric Teaching Hospital, Kigali, Rwanda; 6 Department of Clinical Biology, School of Medicine and Pharmacy, University of Rwanda, Kigali, Rwanda; 7 Department of Pathology, University Teaching Hospital of Kigali, Kigali, Rwanda; 8 School of Medicine and Public Health, University of Newcastle, Callaghan, NSW, Australia; 9 School of Economics and Business, College of Business and Economics, University of Johannesburg, Johannesburg, South Africa; 10 Department of Mathematics and Applied Mathematics, University of Johannesburg, Johannesburg, South Africa; 11 Department of Statistics, University of South Africa, Pretoria, South Africa Correspondence: Jean Pierre Gafaranga, Department of Psychiatry and Behavioral Sciences, School of Medicine and Pharmacy, University of Rwanda, Kigali, Rwanda, Tel +250788224864, Email ; Background: Depression is a significant global public health concern, affecting individuals across different age groups and cultural backgrounds. However, screening for depression remains an essential but often neglected aspect of healthcare, particularly in outpatient settings. This study aimed to assess the prevalence of depression among outpatients visiting the internal medicine department of the University Teaching Hospital of Kigali in Rwanda and evaluate the feasibility of implementing a depression screening program in this setting. Methods: An institution-based cross-sectional study design was employed, involving 300 adult medical outpatients through convenience sampling, aged 18 years and above, who visited the internal medicine department between October 7 to November 6, 2019. The Patient Health Questionnaire-9 (PHQ-9) was used as the screening tool to assess depressive symptoms. Additionally, socio-demographic and clinical data were collected to explore potential risk factors associated with depression using a binary logistic regression model. Results: A high prevalence of depression was identified among internal medicine outpatients, with 45.7% of participants screened positive for depression, with moderate, moderately severe, and severe depression accounting for 21%, 17%, and 8%, respectively. The following factors were significantly associated with positive screening for depression: lack of formal education (OR=4.463, p=0.011, 95% CI= [1.410; 14.127]), secondary education (OR=3.402, p=0.003, 95% CI= [1.517; 7.630]), low-income (OR=2.392, p=0.049, 95% CI= [1.003; 5.706]) and headache as a chief complaint (OR=3.611, p=0.001, CI= [1.718; 7.591]). Conclusion: This study highlights the high prevalence of depression among medical outpatients. Due to the stigma associated with mental health, patients frequently seek help for physical symptoms such as headaches and other bodily complaints rather than mental health concerns. Introducing routine depression screening in medical departments could potentially facilitate early identification, and intervention, and lead to improved patient care. Future research should focus on evaluating such screening programs' effectiveness and long-term outcomes in resource-limited settings like Rwanda. Keywords: depression, screening, medical outpatients, internal medicine department Depression is a common mental health problem and can affect both the mental and physical status of the patient. 1 The global prevalence of depression has been increasing worldwide in the past period, and the highest prevalence has been reported in the African region where Rwanda is located. 1,2 Based on findings from the 2018 Rwanda Mental Health Survey, depression emerges as the predominant mental health disorder, affecting 12% of the 19,110 individuals surveyed across the general population and a significantly higher proportion, 35%, among survivors of the genocide 3 The prevalence of depression varies with age and gender. 1,2 The lower rate is recorded in those aged less than 15 years old and a higher rate in older adults. 2 The data estimate more than 7.5% among f -Abstract Truncated-

Screening and management of depression among patients on TB treatment in Papumpare district, Arunachal Pradesh, India.

Depression: A Neglected Comorbidity in Patients with Tuberculosis

Conceptualization, detection, and management of psychological distress and mental health conditions among people with tuberculosis in Zambia: a qualitative study with stakeholders' and TB health workers

Depression care integration in tuberculosis services: A feasibility assessment in Pakistan

Validation of the Nine-Item Patient Health Questionnaire to Screen for Major Depression in A Chinese Primary Care Population

Possible depression in new tuberculosis patients in the Free State province, South Africa

Impact of integrating mental health services within existing tuberculosis treatment facilities

Psychiatric morbidity among patients on treatment for tuberculosis at a tertiary referral hospital in Western Kenya

Comorbidity of mental ill-health in tuberculosis patients under treatment in a rural province of South Africa: a cross-sectional survey

Bringing state-of-the-art diagnostics to vulnerable populations: The use of a mobile screening unit in active case finding for tuberculosis in Palawan, the Philippines

Prevalence and Associated Factors of Depression and Anxiety Among Patients with Pulmonary Tuberculosis Attending Treatment at Public Health Facilities in Southwest Ethiopia

Depression, anxiety and medication adherence among tuberculosis patients attending treatment centres in Fako Division, Cameroon: cross-sectional study

Under detection of depression in primary care settings in low and middle-income countries: a systematic review and meta-analysis

Assessment of Psychiatric Illness among Pulmonary Tuberculosis Patients at a Tertiary Care Center in India

Accuracy of alternative PHQ-9 scoring algorithms to screen for depression in people living with HIV in Sub-Saharan Africa

Effectiveness of a task-sharing collaborative care model for the detection and management of depression among adults receiving antiretroviral therapy in primary care facilities in South Africa: A pragmatic cluster randomised controlled trial

Screening of Depression Among Medical Outpatients Visiting the University Teaching Hospital of Kigali, Rwanda

TB treatment using family members, treatment supporters and self-administered therapies in rural Papua New Guinea

The Invisible Toll: Unveiling the Prevalence and Predictors of Depression and Anxiety Among Pulmonary Tuberculosis (TB) Patients and Their Households in Gujarat, India

Psychometrics of the Patient Health Questionnaire (PHQ-9) in Uganda: A Systematic Review

Cognitive therapy for depression in tuberculosis treatment: protocol for multicentre pragmatic parallel arm randomised control trial with an internal pilot